Shine Investment Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$76K Hold
865
0.03% 234
2020
Q2
$85K Hold
865
0.03% 214
2020
Q1
$66K Sell
865
-2,667
-76% -$227K 0.03% 231
2019
Q4
$313K Buy
3,532
+2,927
+484% +$243K 0.12% 96
2019
Q3
$46K Buy
605
+8
+1% +$548 0.02% 319
2019
Q2
$43K Hold
597
0.02% 328
2019
Q1
$48K Buy
597
+97
+19% +$7.93K 0.02% 305
2018
Q4
$46K Hold
500
0.02% 292
2018
Q3
$47K Hold
500
0.02% 308
2018
Q2
$46K Hold
500
0.02% 326
2018
Q1
$47K Hold
500
0.03% 311
2017
Q4
$48K Hold
500
0.02% 316
2017
Q3
$44K Hold
500
0.02% 320
2017
Q2
$36K Buy
+500
New +$33.6K 0.02% 335

Other funds holding ABBV

Shine Investment Advisory Services's ABBV Position: Q3 2020 in Review

Shine Investment Advisory Services held its AbbVie (ABBV) position steady in Q3 2020 at 865 shares worth $76K. The position accounts for 0.03% of the portfolio, ranked #234.

Shine Investment Advisory Services first reported a position in ABBV in Q2 2017 and has held it in 14 quarters since. The position peaked at $313K in Q4 2019. 2,367 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Shine Investment Advisory Services held 865 shares of AbbVie worth $76K as of Q3 2020.
  • Shine Investment Advisory Services left its AbbVie share count unchanged in Q3 2020.
  • AbbVie made up 0.03% of Shine Investment Advisory Services's portfolio in Q3 2020, its #234 holding.
  • Shine Investment Advisory Services first reported a position in AbbVie in Q2 2017 and has held it in 14 quarters since.
  • Shine Investment Advisory Services's AbbVie position peaked at $313K in Q4 2019.
  • 2,367 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.